Daewoong pharmaceutical Co.,Ltd
069620.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
1,067
Cost of Revenue
516
Gross Profit
551
Gross Margin
51.6%
Operating Income
111
Operating Margin
10.4%
Net Income
19
Net Margin
1.7%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
84
EBITDA Margin
7.9%
2023
12/31/2023
Revenue
1,031
Cost of Revenue
516
Gross Profit
515
Gross Margin
50.0%
Operating Income
92
Operating Margin
8.9%
Net Income
84
Net Margin
8.1%
EPS (Basic)
$8.00
EPS (Diluted)
$8.00
EBITDA
124
EBITDA Margin
12.0%
2022
12/31/2022
Revenue
960
Cost of Revenue
481
Gross Profit
479
Gross Margin
49.9%
Operating Income
72
Operating Margin
7.5%
Net Income
32
Net Margin
3.3%
EPS (Basic)
$3.00
EPS (Diluted)
$3.00
EBITDA
64
EBITDA Margin
6.6%
2021
12/31/2021
Revenue
865
Cost of Revenue
456
Gross Profit
409
Gross Margin
47.2%
Operating Income
67
Operating Margin
7.7%
Net Income
18
Net Margin
2.1%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
52
EBITDA Margin
6.0%
2020
12/31/2020
Revenue
792
Cost of Revenue
456
Gross Profit
335
Gross Margin
42.3%
Operating Income
13
Operating Margin
1.6%
Net Income
10
Net Margin
1.2%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
47
EBITDA Margin
6.0%